Redpoint Investment Management Pty LTD Bio Rad Laboratories, Inc. Transaction History
Redpoint Investment Management Pty LTD
- $684 Million
- Q3 2022
A detailed history of Redpoint Investment Management Pty LTD transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 709 shares of BIO stock, worth $162,467. This represents 0.04% of its overall portfolio holdings.
Number of Shares
709
Previous 810
12.47%
Holding current value
$162,467
Previous $401,000
26.18%
% of portfolio
0.04%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$438 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$359 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$355 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$209 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$201 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.64B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...